Devyser NIPT RHD
Benefit from proven, highly sensitive technology to conduct accurate non-invasive screening for fetal RHD that helps clinicians avoid untargeted and unnecessary treatment.
Benefit from proven, highly sensitive technology to conduct accurate non-invasive screening for fetal RHD that helps clinicians avoid untargeted and unnecessary treatment.
Abacus dx is pleased to announce that we have been appointed the exclusive distributor for Devyser in Australia and New Zealand.